CA Stock MarketDetailed Quotes

CPH Cipher Pharmaceuticals Inc

Watchlist
  • 14.510
  • +0.010+0.07%
15min DelayTrading Nov 19 15:16 ET
371.30MMarket Cap17.03P/E (TTM)

Cipher Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-66.47%2M
111.30%6.23M
-47.82%2.43M
49.17%16M
77.07%2.42M
41.86%5.97M
-7.91%2.95M
138.99%4.67M
-22.36%10.73M
-76.12%1.37M
Net income from continuing operations
-95.97%283K
-2.47%3M
87.47%4.92M
-23.48%20.38M
-61.10%7.66M
165.02%7.03M
42.64%3.07M
22.20%2.63M
243.34%26.64M
600.39%19.68M
Operating gains losses
-174.88%-325K
189.51%401K
9,271.43%642K
-2,322.86%-778K
-696.84%-757K
502.78%434K
-697.33%-448K
58.82%-7K
-93.75%35K
-733.33%-95K
Depreciation and amortization
615.61%1.93M
-14.62%292K
-15.74%289K
24.06%1.23M
-19.94%273K
-20.41%269K
120.65%342K
121.29%343K
41.08%989K
124.34%341K
Remuneration paid in stock
-7.62%291K
-12.44%183K
-49.55%224K
195.29%1.19M
-5.13%222K
275.00%315K
344.68%209K
1,068.42%444K
189.93%403K
836.00%234K
Deferred tax
101.07%43K
-2,900.00%-480K
-12,933.33%-1.96M
80.87%-2.74M
109.00%1.32M
-1,865.35%-4.03M
-112.80%-16K
---15K
-12,452.63%-14.31M
-8,091.62%-14.66M
Other non cashItems
1,550.00%33K
200.00%6K
100.00%6K
-266.67%-10K
-950.00%-17K
--2K
--2K
--3K
-93.48%6K
--2K
Change In working capital
-112.75%-248K
1,421.50%2.83M
-233.36%-1.7M
-7.98%-3.28M
-51.83%-6.28M
134.34%1.95M
-133.23%-214K
440.75%1.27M
-164.86%-3.03M
-242.88%-4.14M
-Change in receivables
-976.28%-9.44M
1,481.90%4.66M
-354.37%-3.35M
1,290.28%1.71M
376.20%1.61M
-178.58%-877K
-171.70%-337K
214.75%1.32M
-105.62%-144K
-307.83%-584K
-Change in inventory
-31.55%230K
72.97%-130K
192.64%214K
-65.34%-830K
-488.03%-454K
1,780.00%336K
-27.59%-481K
-4.05%-231K
33.77%-502K
147.37%117K
-Change in prepaid assets
-113.90%-477K
9.26%118K
-205.13%-41K
-89.00%11K
166.41%87K
-325.25%-223K
500.00%108K
-75.47%39K
-73.26%100K
-177.51%-131K
-Change in payables and accrued expense
-41.07%1.6M
-474.85%-1.83M
1,151.67%1.5M
-93.16%-4.43M
-135.92%-7.76M
852.08%2.72M
-17.68%489K
-84.21%120K
-197.37%-2.3M
-215.09%-3.29M
-Change in other working capital
130,733.33%7.84M
128.57%16K
-189.29%-25K
235.75%262K
193.57%233K
-50.00%-6K
143.75%7K
-63.16%28K
-234.97%-193K
-50.00%-249K
Cash from discontinued investing activities
Operating cash flow
-66.47%2M
111.30%6.23M
-47.82%2.43M
49.17%16M
77.07%2.42M
41.86%5.97M
-7.91%2.95M
138.99%4.67M
-22.36%10.73M
-76.12%1.37M
Investing cash flow
Cash flow from continuing investing activities
-80.02M
-11K
-6K
-77.78%-144K
-144K
0
0
0
-81K
0
Net PPE purchase and sale
---20K
---11K
---6K
74.07%-21K
---21K
--0
--0
--0
---81K
--0
Net intangibles purchas and sale
----
----
----
---123K
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
---80.02M
---11K
---6K
-77.78%-144K
---144K
--0
--0
--0
---81K
--0
Financing cash flow
Cash flow from continuing financing activities
146,418.52%39.51M
97.93%-5K
-197.06%-101K
-174.27%-5.24M
-2,528.19%-4.94M
90.72%-27K
65.28%-242K
95.38%-34K
22.59%-1.91M
76.02%-188K
Net issuance payments of debt
137,741.38%39.92M
-38.10%-29K
-12.00%-28K
-98.21%-111K
-50.00%-36K
9.38%-29K
---21K
---25K
93.24%-56K
---24K
Net common stock issuance
--0
--0
-144.44%-176K
-179.63%-5.56M
-2,340.67%-5.1M
53.02%-132K
66.09%-254K
90.39%-72K
-15.78%-1.99M
73.61%-209K
Proceeds from stock option exercised by employees
-92.54%10K
-27.27%24K
63.49%103K
222.73%426K
335.56%196K
509.09%134K
-36.54%33K
384.62%63K
76.00%132K
462.50%45K
Cash from discontinued financing activities
Financing cash flow
146,418.52%39.51M
97.93%-5K
-197.06%-101K
-174.27%-5.24M
-2,528.19%-4.94M
90.72%-27K
65.28%-242K
95.38%-34K
22.59%-1.91M
76.02%-188K
Net cash flow
Beginning cash position
32.05%47.98M
25.59%41.98M
38.11%39.83M
40.33%28.84M
53.17%42.09M
50.21%36.34M
52.98%33.43M
40.33%28.84M
124.76%20.55M
75.82%27.48M
Current changes in cash
-747.91%-38.51M
129.62%6.21M
-49.75%2.33M
21.52%10.61M
-326.68%-2.67M
54.91%5.94M
8.07%2.7M
280.84%4.63M
-23.03%8.73M
-76.14%1.18M
Effect of exchange rate changes
126.53%52K
-199.52%-206K
-327.50%-171K
185.14%378K
123.63%407K
64.43%-196K
228.57%207K
-146.51%-40K
-816.13%-444K
1,500.00%182K
End cash Position
-77.37%9.52M
32.05%47.98M
25.59%41.98M
38.11%39.83M
38.11%39.83M
53.17%42.09M
50.21%36.34M
52.98%33.43M
40.33%28.84M
40.33%28.84M
Free cash from
-66.81%1.98M
110.93%6.21M
-47.95%2.43M
48.96%15.86M
66.52%2.27M
44.65%5.97M
-7.91%2.95M
138.99%4.67M
-22.95%10.64M
-76.12%1.37M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -66.47%2M111.30%6.23M-47.82%2.43M49.17%16M77.07%2.42M41.86%5.97M-7.91%2.95M138.99%4.67M-22.36%10.73M-76.12%1.37M
Net income from continuing operations -95.97%283K-2.47%3M87.47%4.92M-23.48%20.38M-61.10%7.66M165.02%7.03M42.64%3.07M22.20%2.63M243.34%26.64M600.39%19.68M
Operating gains losses -174.88%-325K189.51%401K9,271.43%642K-2,322.86%-778K-696.84%-757K502.78%434K-697.33%-448K58.82%-7K-93.75%35K-733.33%-95K
Depreciation and amortization 615.61%1.93M-14.62%292K-15.74%289K24.06%1.23M-19.94%273K-20.41%269K120.65%342K121.29%343K41.08%989K124.34%341K
Remuneration paid in stock -7.62%291K-12.44%183K-49.55%224K195.29%1.19M-5.13%222K275.00%315K344.68%209K1,068.42%444K189.93%403K836.00%234K
Deferred tax 101.07%43K-2,900.00%-480K-12,933.33%-1.96M80.87%-2.74M109.00%1.32M-1,865.35%-4.03M-112.80%-16K---15K-12,452.63%-14.31M-8,091.62%-14.66M
Other non cashItems 1,550.00%33K200.00%6K100.00%6K-266.67%-10K-950.00%-17K--2K--2K--3K-93.48%6K--2K
Change In working capital -112.75%-248K1,421.50%2.83M-233.36%-1.7M-7.98%-3.28M-51.83%-6.28M134.34%1.95M-133.23%-214K440.75%1.27M-164.86%-3.03M-242.88%-4.14M
-Change in receivables -976.28%-9.44M1,481.90%4.66M-354.37%-3.35M1,290.28%1.71M376.20%1.61M-178.58%-877K-171.70%-337K214.75%1.32M-105.62%-144K-307.83%-584K
-Change in inventory -31.55%230K72.97%-130K192.64%214K-65.34%-830K-488.03%-454K1,780.00%336K-27.59%-481K-4.05%-231K33.77%-502K147.37%117K
-Change in prepaid assets -113.90%-477K9.26%118K-205.13%-41K-89.00%11K166.41%87K-325.25%-223K500.00%108K-75.47%39K-73.26%100K-177.51%-131K
-Change in payables and accrued expense -41.07%1.6M-474.85%-1.83M1,151.67%1.5M-93.16%-4.43M-135.92%-7.76M852.08%2.72M-17.68%489K-84.21%120K-197.37%-2.3M-215.09%-3.29M
-Change in other working capital 130,733.33%7.84M128.57%16K-189.29%-25K235.75%262K193.57%233K-50.00%-6K143.75%7K-63.16%28K-234.97%-193K-50.00%-249K
Cash from discontinued investing activities
Operating cash flow -66.47%2M111.30%6.23M-47.82%2.43M49.17%16M77.07%2.42M41.86%5.97M-7.91%2.95M138.99%4.67M-22.36%10.73M-76.12%1.37M
Investing cash flow
Cash flow from continuing investing activities -80.02M-11K-6K-77.78%-144K-144K000-81K0
Net PPE purchase and sale ---20K---11K---6K74.07%-21K---21K--0--0--0---81K--0
Net intangibles purchas and sale ---------------123K------------------0----
Cash from discontinued investing activities
Investing cash flow ---80.02M---11K---6K-77.78%-144K---144K--0--0--0---81K--0
Financing cash flow
Cash flow from continuing financing activities 146,418.52%39.51M97.93%-5K-197.06%-101K-174.27%-5.24M-2,528.19%-4.94M90.72%-27K65.28%-242K95.38%-34K22.59%-1.91M76.02%-188K
Net issuance payments of debt 137,741.38%39.92M-38.10%-29K-12.00%-28K-98.21%-111K-50.00%-36K9.38%-29K---21K---25K93.24%-56K---24K
Net common stock issuance --0--0-144.44%-176K-179.63%-5.56M-2,340.67%-5.1M53.02%-132K66.09%-254K90.39%-72K-15.78%-1.99M73.61%-209K
Proceeds from stock option exercised by employees -92.54%10K-27.27%24K63.49%103K222.73%426K335.56%196K509.09%134K-36.54%33K384.62%63K76.00%132K462.50%45K
Cash from discontinued financing activities
Financing cash flow 146,418.52%39.51M97.93%-5K-197.06%-101K-174.27%-5.24M-2,528.19%-4.94M90.72%-27K65.28%-242K95.38%-34K22.59%-1.91M76.02%-188K
Net cash flow
Beginning cash position 32.05%47.98M25.59%41.98M38.11%39.83M40.33%28.84M53.17%42.09M50.21%36.34M52.98%33.43M40.33%28.84M124.76%20.55M75.82%27.48M
Current changes in cash -747.91%-38.51M129.62%6.21M-49.75%2.33M21.52%10.61M-326.68%-2.67M54.91%5.94M8.07%2.7M280.84%4.63M-23.03%8.73M-76.14%1.18M
Effect of exchange rate changes 126.53%52K-199.52%-206K-327.50%-171K185.14%378K123.63%407K64.43%-196K228.57%207K-146.51%-40K-816.13%-444K1,500.00%182K
End cash Position -77.37%9.52M32.05%47.98M25.59%41.98M38.11%39.83M38.11%39.83M53.17%42.09M50.21%36.34M52.98%33.43M40.33%28.84M40.33%28.84M
Free cash from -66.81%1.98M110.93%6.21M-47.95%2.43M48.96%15.86M66.52%2.27M44.65%5.97M-7.91%2.95M138.99%4.67M-22.95%10.64M-76.12%1.37M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data